NCT07099924View on ClinicalTrials.gov

Rectus Sheath Catheters Following Midline Laparotomy

NANot yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

August 31, 2027

Study Completion Date

September 30, 2027

Conditions
Acute AbdomenIleusColorectal Carcinoma
Interventions
DRUG

Ropivacaine 0.2%

2x30ml (bilateral) ropivacaine 0.2% every 8 hours via rectus sheath catheter

DRUG

Saline 0.9%

2x30ml saline 0.9% every 8 hours via rectus sheath catheter

Trial Locations (1)

16303

Asklepios Medical Center Uckermark, Schwedt

All Listed Sponsors
lead

Asklepios Kliniken Hamburg GmbH

OTHER

NCT07099924 - Rectus Sheath Catheters Following Midline Laparotomy | Biotech Hunter | Biotech Hunter